Characteristiscs
|
Generic Core Scale
|
p-value
|
Cancer
Module
|
p-value
|
Multidimensional Fatigue Module
|
p-value
|
---|
|
Argentina
mean (sd)
|
Sweden
mean (sd)
| |
Argentina
mean (sd)
|
Sweden
mean (sd)
| |
Argentina
mean (sd)
|
Sweden
mean (sd)
| |
---|
Gender
|
Female
|
55.5(16.6)
|
59.2(19.0)
|
0.72
|
68.6(12.2)
|
67.7(15.8)
|
0.88
|
72.8(22.4)
|
68.2(15.5)
|
0.23
|
Male
|
66.9(16.4)
|
58.8(16.6)
|
0.18
|
66.6(14.2)
|
63.1(18.5)
|
0.59
|
77.9(17.7)
|
58.4(17.3)
|
0.002
|
Age groups
|
2 to 4 years
|
69.6(21.7)
|
65.0(19.6)
|
0.51
|
67.9(13.6)
|
72.3(17.4)
|
0.60
|
77.3(26.5)
|
68.1(17.6)
|
0.14
|
5 to 12 years
|
58.1(15.4)
|
62.2(17.1)
|
0.52
|
66.9(13.6)
|
67.9(14.0)
|
0.97
|
78.6(19.1)
|
70.3(12.5)
|
0.15
|
13 to 18 years
|
60.6(12.6)
|
49.5(12.4)
|
0.09
|
67.3(14.1)
|
55.2(17.0)
|
0.18
|
72.4(10.7)
|
49.6(13.6)
|
p < 0.0001
|
Diagnostic groups
|
Leukaemia
|
63.8(16.8)
|
66.6(19.8)
|
0.69
|
69.3(13.9)
|
75.9(15.9)
|
0.22
|
73.8(14.8)
|
77.1(18.9)
|
0.33
|
Solid tumours
|
63.1(22.6)
|
52.3(14.1)
|
0.57
|
62.3(9.3)
|
56.1(15.8)
|
0.46
|
83.1(7.0)
|
52.2(15.2)
|
0.003
|
CNS tumours
|
54.7(10.4)
|
55.6(12.7)
|
1.00
|
63.7(16.6)
|
59.9(11.7)
|
0.79
|
54.6(16.1)
|
59.7(9.4)
|
1.00
|
Treatment modality
|
Chemotherapy
|
65.8(17.1)
|
62.6(18.3)
|
0.60
|
69.0(13.1)
|
70.4(18.6)
|
0.53
|
79.3(18.5)
|
65.7(18.2)
|
0.009
|
Combined therapy
|
47.4(4.2)
|
53.5(15.1)
|
0.23
|
59.3(12.4)
|
57.3(11.1)
|
0.83
|
59.7(15.7)
|
58.7(14.5)
|
0.76
|
- Note: Scores range from 0 to 100; higher scores represent a better HRQOL. Significant differences are highlighted in bold type. sd standard deviation